Serum concentrations of myostatin (MSTN or GDF8), follistatin (FSTN), GDF11 and ACTIVIN A were determined in patients affected by several neuromuscular diseases with various levels of muscle atrophy and in controls (summarized in Table 1 and Supplementary Table 1). This evidence concerns the gene FST and neuromuscular disease.